{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:37:37Z","timestamp":1769189857334,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Arteriovenous fistulas (<jats:styled-content style=\"fixed-case\">AVF<\/jats:styled-content>s) play an important role in access for hemodialysis, yet premature thrombosis is a challenge. This study identifies factors influencing primary patency in a series of <jats:styled-content style=\"fixed-case\">AVF<\/jats:styled-content> creations. Postoperative systolic blood pressure (<jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>) was of principal interest; demographical information, comorbidities, smoking status, warfarin, aspirin, clopidogrel, and statins were considered.<\/jats:p><jats:p>A retrospective review of <jats:styled-content style=\"fixed-case\">AVF<\/jats:styled-content> creations performed by one surgeon between January 2008 and September 2010 was conducted. Fistula patency was denoted by a bruit and measured at 3\u00a0weeks and 12\u00a0months after surgery.<\/jats:p><jats:p>One hundred and fifty\u2010one <jats:styled-content style=\"fixed-case\">AVF<\/jats:styled-content> creations were studied; 134 fistulas (88.7%) were patent at 3\u00a0weeks and 85 (56.3%) at 12\u00a0months. The odds ratio (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>) for thrombosis at 12\u00a0months was 0.16 (95% CI: 0.04, 0.62; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.008) among patients with a postoperative systolic <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> of 120\u2013139\u00a0mmHg compared with those with a <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> of \u2264119\u00a0mmHg. Patients taking warfarin yielded an <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> of 5.71 at 3\u00a0weeks (95% CI: 1.20, 27.11; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.028), and 3.33 at 12\u00a0months (95% CI: 1.01, 10.99; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.048). No other variables were statistically significant.<\/jats:p><jats:p>Patients with postoperative systolic <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> of 120\u2013139\u00a0mmHg showed a reduction in fistula thromboses compared with patients with a systolic <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> of \u2264119\u00a0mmHg. Patients on warfarin were less likely to maintain a patent fistula.<\/jats:p>","DOI":"10.1111\/sdi.12163","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T09:42:44Z","timestamp":1386668564000},"source":"Crossref","is-referenced-by-count":9,"title":["Do Blood Pressure Levels and Other Patient Characteristics Influence Native Fistula Patency?"],"prefix":"10.1111","volume":"27","author":[{"given":"Jeyna","family":"Irvinn","sequence":"first","affiliation":[{"name":"St George's Hospital Medical School London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Oldman","sequence":"additional","affiliation":[{"name":"St George's Hospital Medical School London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Sedgwick","sequence":"additional","affiliation":[{"name":"St George's Hospital Medical School London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chemla","sequence":"additional","affiliation":[{"name":"Vascular Surgery Institute St George's Hospital London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"NHS Choices:Dialysis: Introduction[webpage online]. Available athttp:\/\/www.nhs.uk\/conditions\/dialysis\/Pages\/Introduction.aspx acces\u2010sed April 3 2013"},{"key":"e_1_2_5_3_1","unstructured":"Kidney Disease Outcomes Quality Initiative:NKF KDOQI Guidelines: clinical practice guidelines for hemodialysis adequacy[webpage online]. Available athttp:\/\/www.kidney.org\/professionals\/KDOQI\/guideline_upHD_PD_VA\/hd_guide1.htm accessed April 3 2013"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.18.2164"},{"key":"e_1_2_5_5_1","unstructured":"Kidney Disease Outcomes Quality Initiative:NKF KDOQI Guidelines: Clinical practice guidelines for vascular access; guideline 1[webpage online]. Available athttp:\/\/www.kidney.org\/professionals\/KDOQI\/guideline_upHD_PD_VA\/va_guide1.htm accessed April 3 2013"},{"key":"e_1_2_5_6_1","volume-title":"Kidney Disease: Key Fact and Figures, September 2010","author":"NHS Kidney Care","year":"2010"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-007-0662-6"},{"key":"e_1_2_5_8_1","unstructured":"Kidney Disease Outcomes Quality Initiative:NKF KDOQI Guidelines: Clinical practice guidelines for vascular access; guideline 2[webpage online]. Available athttp:\/\/www.kidney.org\/professionals\/KDOQI\/guideline_upHD_PD_VA\/va_guide2.htm accessed April 3 2013"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2008.00449.x"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.04.018"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000069219.88168.39"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1191\/1740774505cn118oa"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/112972980800900401"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs269"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00740.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.5301\/JVA.2011.8349"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00310.x"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90655-X"},{"key":"e_1_2_5_19_1","first-page":"306","article-title":"Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis","volume":"43","author":"Pu\u0161kar D","year":"2002","journal-title":"Croat Med J"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02910608"},{"key":"e_1_2_5_21_1","unstructured":"National Institute for Health and Clinical Excellence.Hypertension: clinical management of primary hypertension in adults[webpage online]. Available athttp:\/\/www.nice.org.uk\/nicemedia\/live\/13561\/56008\/56008.pdf accessed April 3 2013"},{"key":"e_1_2_5_22_1","unstructured":"World Health Organization:Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia[webpage online]. Available athttp:\/\/whqlibdoc.who.int\/publications\/2006\/9241594934_eng.pdf accessed April 3 2013"},{"key":"e_1_2_5_23_1","unstructured":"National Institute for Health and Clinical Excellence:Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Available athttp:\/\/www.nice.org.uk\/nicemedia\/live\/11982\/40689\/40689.pdf accessed April 3 2013"},{"key":"e_1_2_5_24_1","unstructured":"National Health Service:National Service Framework for Coronary Heart Disease[webpage online] Available athttps:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/198931\/National_Service_Framework_for_Coronary_Heart_Disease.pdf accessed April 3 2013"},{"key":"e_1_2_5_25_1","unstructured":"National Institute for Health and Clinical Excellence:NICE public health guidance 25: Prevention of cardiovascular disease. Available athttp:\/\/www.nice.org.uk\/nicemedia\/live\/13024\/49273\/49273.pdf accessed April 3 2013"},{"key":"e_1_2_5_26_1","unstructured":"Fistula First:Monitoring and maintenance to ensure adequate access function[web page online]. Available athttp:\/\/www.fistulafirst.org\/HealthcareProfessionals\/FFBIChangeConcepts\/ChangeConcept9.aspx accessed April 3 2013"},{"key":"e_1_2_5_27_1","first-page":"466","volume-title":"Oxford Concise Medical Dictionary","year":"2007"},{"key":"e_1_2_5_28_1","unstructured":"Blood Pressure UK; [webpage online]. Available athttp:\/\/www.bloodpressureuk.org\/BloodPressureandyou\/Thebasics\/Bloodpressurechart accessed April 6 2013"},{"key":"e_1_2_5_29_1","unstructured":"The Renal Association:Haemodialysis; prevention of adverse events during haemodialysis[webpage online] Available athttp:\/\/www.renal.org\/Clinical\/GuidelinesSection\/Haemodialysis.aspx#f8 accessed April 3 2013"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36895"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs346"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.07.095"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.07.019"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsdi.12163","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T23:33:09Z","timestamp":1696203189000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sdi.12163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1111\/sdi.12163"],"URL":"https:\/\/doi.org\/10.1111\/sdi.12163","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}